Literature DB >> 12666996

New sensitive method for the measurement of lysozyme and lactoferrin for the assessment of innate mucosal immunity. part I: time-resolved immunofluorometric assay in serum and mucosal secretions.

Emmanuel Bard1, Sophy Laibe, Dominique Bettinger, Didier Riethmuller, Sabeha Biichlé, Estelle Seilles, Dominique Meillet.   

Abstract

Mucous peristalsis, mucus and immunity proteins, such as lysozyme and lactoferrin, are part of humoral innate immunity. The aim of this study was to develop a quantitative method, a time-resolved-immunofluorometric assay, to measure lysozyme and lactoferrin in sera, saliva, stools and cervico-vaginal secretions. This method was validated in 51 healthy subjects. Linearity for lysozyme was between 1.02 and 25 microg/l and for lactoferrin between 1.02 and 100 microg/l. The detection limit was 0.5 microg/l for lysozyme and 1 microg/l for lactoferrin. Albumin and alpha1-antitrypsin were measured by immuno-nephelometry to calculate salivary, intestinal and cervico-vaginal coefficients of excretion. Lysozyme and lactoferrin were present in all types of mucosal surfaces. Very high concentrations of lysozyme and lactoferrin were found in cervico-vaginal fluid (166.2 and 72.7 mg/l, respectively), compared to the concentrations found in the other mucosal fluids. Lysozyme in stools was produced at the rate of 0.42 mg/d compared to 0.02 mg/d lactoferrin production. Lysozyme and lactoferrin greatly exceeded the values expected from the molecular weight-affected seepage from plasma, suggesting primarily local synthesis in healthy subjects. Quantitative measurement of lysozyme and lactoferrin can aid in the assessment of the activity of mucus-associated lymphoid tissues in innate immunity, and can help in further understanding of the role of these proteins in mucosal diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12666996     DOI: 10.1515/CCLM.2003.021

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  8 in total

1.  Clinical trials of yeast-derived β-(1,3) glucan in children: effects on innate immunity.

Authors:  Josef Richter; Vladimir Svozil; Vlastimil Král; Lucie Rajnohová Dobiášová; Ivana Stiborová; Vaclav Vetvicka
Journal:  Ann Transl Med       Date:  2014-02

2.  Placebo-driven clinical trials of yeast-derived β-(1-3) glucan in children with chronic respiratory problems.

Authors:  Vaclav Vetvicka; Josef Richter; Vladimir Svozil; Lucie Rajnohová Dobiášová; Vlastimil Král
Journal:  Ann Transl Med       Date:  2013-10

3.  A role for antimicrobial peptides in intestinal microsporidiosis.

Authors:  G J Leitch; C Ceballos
Journal:  Parasitology       Date:  2008-12-12       Impact factor: 3.234

4.  The plasmid-encoded regulator activates factors conferring lysozyme resistance on enteropathogenic Escherichia coli strains.

Authors:  Nina Salinger; Bashkim Kokona; Robert Fairman; Iruka N Okeke
Journal:  Appl Environ Microbiol       Date:  2008-11-07       Impact factor: 4.792

5.  The effects of reproductive hormones on the physical properties of cervicovaginal fluid.

Authors:  Catherine A Chappell; Lisa C Rohan; Bernard J Moncla; Lin Wang; Leslie A Meyn; Katherine Bunge; Sharon L Hillier
Journal:  Am J Obstet Gynecol       Date:  2014-03-21       Impact factor: 8.661

6.  Studying the effects of reproductive hormones and bacterial vaginosis on the glycome of lavage samples from the cervicovaginal cavity.

Authors:  Linlin Wang; Sujeethraj Koppolu; Catherine Chappell; Bernard J Moncla; Sharon L Hillier; Lara K Mahal
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

7.  The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria.

Authors:  Douglas B Kell; Eugene L Heyden; Etheresia Pretorius
Journal:  Front Immunol       Date:  2020-05-28       Impact factor: 7.561

8.  The Protozoan Trichomonas vaginalis Targets Bacteria with Laterally Acquired NlpC/P60 Peptidoglycan Hydrolases.

Authors:  Jully Pinheiro; Jacob Biboy; Waldemar Vollmer; Robert P Hirt; Jeremy R Keown; Anastasiia Artuyants; Moyra M Black; David C Goldstone; Augusto Simoes-Barbosa
Journal:  mBio       Date:  2018-12-11       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.